Journal of the Royal Society of Medicine最新文献

{"title":"Social media interventions for non-communicable diseases: a call for a holistic approach considering eating disorders, mental health and wellbeing.","authors":"Avani Ela, Georgia Peers, Richard J Pinder, Azeem Majeed, Shyam Sundar Budhathoki","doi":"10.1177/01410768241290306","DOIUrl":"https://doi.org/10.1177/01410768241290306","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241290306"},"PeriodicalIF":8.8,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142687408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Doctors working in teams.","authors":"Dinesh Bhugra","doi":"10.1177/01410768241289860","DOIUrl":"10.1177/01410768241289860","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241289860"},"PeriodicalIF":8.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Using recruitment data instead of national population ethnicity proportions in clinical trial preparation may introduce bias.","authors":"H Logan Ellis, J Smith, A M Murtagh, M Al-Agil, M B Whyte","doi":"10.1177/01410768241299529","DOIUrl":"10.1177/01410768241299529","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241299529"},"PeriodicalIF":8.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"How to deal with bullying, harassment and discrimination in the workplace?","authors":"Dinesh Bhugra","doi":"10.1177/01410768241289863","DOIUrl":"10.1177/01410768241289863","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241289863"},"PeriodicalIF":8.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trusting in lived experience.","authors":"Donald A Redelmeier, Edward E Etchells, Umberin Najeeb","doi":"10.1177/01410768241288343","DOIUrl":"10.1177/01410768241288343","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241288343"},"PeriodicalIF":8.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142668212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmaceutical industry payments to healthcare professional organisations in the United Kingdom: a seven-year cross-sectional analysis of the Disclosure UK database from 2015 to 2021.","authors":"Anju Murayama, Alice Fabbri, Hannah Scholfield, Piotr Ozieranski","doi":"10.1177/01410768241297441","DOIUrl":"10.1177/01410768241297441","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to examine the size and trends in payments from the pharmaceutical industry to healthcare professional organisations (HPOs) in the United Kingdom (UK), and to characterise the conflict of interest (COI) management plans by HPOs who received large payments.</p><p><strong>Design: </strong>Cross-sectional analysis of non-research payments disclosed in the Disclosure UK database from 2015 to 2021.</p><p><strong>Setting: </strong>United Kingdom.</p><p><strong>Participants: </strong>148 pharmaceutical companies disclosing payment data and HPOs receiving the largest payments.</p><p><strong>Main outcome measures: </strong>Total value and median of payments per HPO; existence and content of COI policies among HPOs receiving the largest payments.</p><p><strong>Results: </strong>A total of 898 HPOs received non-research payments worth £99.9 million (17.4% of non-research payments to all healthcare organisations). The median seven-year payment per HPO was £4509 (interquartile range: £943-£30,360). The annual payments nearly doubled from £9.3 million in 2015 to £17.6 million in 2021. Event payments constituted the largest share (£68.2 million, 68.2%). HPOs representing physicians received over 91.5% (£91.5 million) of all payments, while those related to endocrinology and diabetology - 16.3% (£16.3 million). Over 59.9% (£59.9 million) went to the 30 top-funded HPOs, of which only 17 (56.7%) had a publicly accessible COI policy. However, just 6 (35.3%) of these policies included provisions for payments from external organisations.</p><p><strong>Conclusions: </strong>HPOs received nearly one-fifth of pharmaceutical company payments to the UK healthcare sector. These payments were concentrated among a small number of HPOs, which often lacked effective policies for management of COI and payments from the industry.</p>","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241297441"},"PeriodicalIF":8.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Deriving and validating a risk prediction model for long COVID: a population-based, retrospective cohort study in Scotland.","authors":"Karen Jeffrey, Vicky Hammersley, Rishma Maini, Anna Crawford, Lana Woolford, Ashleigh Batchelor, David Weatherill, Chris White, Tristan Millington, Robin Kerr, Siddharth Basetti, Calum Macdonald, Jennifer K Quint, Steven Kerr, Syed Ahmar Shah, Amanj Kurdi, Colin R Simpson, Srinivasa Vittal Katikireddi, Igor Rudan, Chris Robertson, Lewis Ritchie, Aziz Sheikh, Luke Daines","doi":"10.1177/01410768241297833","DOIUrl":"10.1177/01410768241297833","url":null,"abstract":"<p><strong>Objectives: </strong>Using electronic health records, we derived and internally validated a prediction model to estimate risk factors for long COVID and predict individual risk of developing long COVID.</p><p><strong>Design: </strong>Population-based, retrospective cohort study.</p><p><strong>Setting: </strong>Scotland.</p><p><strong>Participants: </strong>Adults (≥18 years) with a positive COVID-19 test, registered with a general medical practice between 1 March 2020 and 20 October 2022.</p><p><strong>Main outcome measures: </strong>Adjusted odds ratios (aORs) with 95% confidence intervals (CIs) for predictors of long COVID, and patients' predicted probabilities of developing long COVID.</p><p><strong>Results: </strong>A total of 68,486 (5.6%) patients were identified as having long COVID. Predictors of long COVID were increasing age (aOR: 3.84; 95% CI: 3.66-4.03 and aOR: 3.66; 95% CI: 3.27-4.09 in first and second splines), increasing body mass index (BMI) (aOR: 3.17; 95% CI: 2.78-3.61 and aOR: 3.09; 95% CI: 2.13-4.49 in first and second splines), severe COVID-19 (aOR: 1.78; 95% CI: 1.72-1.84); female sex (aOR: 1.56; 95% CI: 1.53-1.60), deprivation (most versus least deprived quintile, aOR: 1.40; 95% CI: 1.36-1.44), several existing health conditions. Predictors associated with reduced long COVID risk were testing positive while Delta or Omicron variants were dominant, relative to when the Wild-type variant was dominant (aOR: 0.85; 95% CI: 0.81-0.88 and aOR: 0.64; 95% CI: 0.61-0.67, respectively) having received one or two doses of COVID-19 vaccination, relative to unvaccinated (aOR: 0.90; 95% CI: 0.86-0.95 and aOR: 0.96; 95% CI: 0.93-1.00).</p><p><strong>Conclusions: </strong>Older age, higher BMI, severe COVID-19 infection, female sex, deprivation and comorbidities were predictors of long COVID. Vaccination against COVID-19 and testing positive while Delta or Omicron variants were dominant predicted reduced risk.</p>","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241297833"},"PeriodicalIF":8.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574934/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The constitution, functions and skill sets of teams.","authors":"Dinesh Bhugra","doi":"10.1177/01410768241289856","DOIUrl":"10.1177/01410768241289856","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241289856"},"PeriodicalIF":8.8,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11574927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142648369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Food in Daniel 1:1-16: the first report of a controlled experiment?","authors":"Susan Weingarten","doi":"10.1177/01410768241294253","DOIUrl":"10.1177/01410768241294253","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241294253"},"PeriodicalIF":8.8,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Underpowered trials at trial start and informed consent: action is needed beyond the COVID-19 pandemic.","authors":"Rafael Dal-Ré, Stefan Eriksson, Stephen R Latham","doi":"10.1177/01410768241290075","DOIUrl":"10.1177/01410768241290075","url":null,"abstract":"","PeriodicalId":17271,"journal":{"name":"Journal of the Royal Society of Medicine","volume":" ","pages":"1410768241290075"},"PeriodicalIF":8.8,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142639074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}